S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RVNC Revance Therapeutics Inc

3.65

0.00 (0.00%)

After Hours

Last Updated: 19:00:00

15 min delayed - Upgrade to Realtime

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Apr 2025 to May 2025

Click Here for more Revance Therapeutics Charts.

Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From May 2024 to May 2025

Click Here for more Revance Therapeutics Charts.

Revance Therapeutics Inc News

Form 15-12G - Securities registration termination [Section 12(g)]
Tuesday 18 February 2025 (3 months ago) • Edgar (US Regulatory)

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC
Thursday 13 February 2025 (3 months ago) • PR Newswire (US)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Wednesday 12 February 2025 (3 months ago) • Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement
Wednesday 12 February 2025 (3 months ago) • Edgar (US Regulatory)

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc.(RVNC) Shareholders
Monday 10 February 2025 (3 months ago) • PR Newswire (US)

Crown Laboratories Completes Acquisition of Revance Therapeutics
Friday 7 February 2025 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 months ago) • Edgar (US Regulatory)

More Revance Therapeutics Inc News Articles

Fannie Mae (QB)

Valiant Eagle (PK)

Seafarer Exploration (PK)

CyberFuels (PK)

Bell Buckle (PK)

American Diversified (PK)

TPT Global Tech (CE)

Movement Industries (PK)

Lehman Brothers Financial (CE)

Accredited Solutions (PK)

Ethema Health (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions